Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

Viatrac 14 Plus Peripheral Dilatation Catheter

K-Number: K221057 · 2022-05-05

Decision Date2022-05-05
Product CodeLIT
Advisory CommitteeCV
DecisionSubstantially Equivalent

Device Summary

Viatrac 14 Plus Peripheral Dilatation Catheter is a medical device manufactured by Abbott Vascular. It received FDA 510(k) clearance on 2022-05-05 under approval number K221057. The device is classified under product code LIT. It was reviewed by the CV advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the Viatrac 14 Plus Peripheral Dilatation Catheter?

Viatrac 14 Plus Peripheral Dilatation Catheter is a medical device that received FDA 510(k) clearance on 2022-05-05. It is manufactured by Abbott Vascular. The 510(k) number is K221057.

When was Viatrac 14 Plus Peripheral Dilatation Catheter approved by the FDA?

Viatrac 14 Plus Peripheral Dilatation Catheter received FDA 510(k) clearance on 2022-05-05, under approval number K221057.

What company makes Viatrac 14 Plus Peripheral Dilatation Catheter?

Viatrac 14 Plus Peripheral Dilatation Catheter is manufactured by Abbott Vascular.

What is the FDA product code for Viatrac 14 Plus Peripheral Dilatation Catheter?

The FDA product code for Viatrac 14 Plus Peripheral Dilatation Catheter is LIT.

Related Clinical Trials

Other Devices by Abbott Vascular

View all 15 devices →

Related Devices (Code: LIT)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.